The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Open accessAbstract
The immunoglobulin light-chain gene enhancers E kappa 3', E lambda 2-4, and E lambda 3-1 contain a conserved cell type-specific composite element essential for their activities. This element binds a B cell-specific heterodimeric protein complex that consists of the Ets family member PU.1 and a second factor (NF-EM5), whose participation in the formation of the complex is dependent on the presence of DNA-bound PU.1. In this report we describe the cloning and characterization of Pip (PU.1 interaction partner), a lymphoid-specific protein that is most likely NF-EM5. As expected, the Pip protein binds the composite element only in the presence of PU.1; furthermore, the formation of this ternary complex is critically dependent on phosphorylation of PU.1 at serine-148. The Pip gene is expressed specifically in lymphoid tissues in both B- and T-cell lines. When coexpressed in NIH-3T3 cells, Pip and PU.1 function as mutually dependent transcription activators of the composite element. The amino-terminal DNA-binding domain of Pip exhibits a high degree of homology to the DNA-binding domains of members of the interferon regulatory factor (IRF) family, which includes IRF-1, IRF-2, ICSBP, and ISGF3 gamma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“When co-expressed ectopically, PU.1 and Pip synergistically activate transcription of a reporter gene containing multiple copies of the composite element from the IgL λ enhancer, E λ2-4 (Eisenbeis et al., 1995).”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Eisenbeis et al., 1995
The cited source says what the claim attributes to it.
In the citing paper
“In several studies, the physical interaction between transcription factors increases DNA-binding ability, providing an explanation for synergistic activation in the presence of two factors (11,18,56,58,67).”
From Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1 (1998) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“The PU.1-and Pip-binding sites have been underlined based on methylation interference analysis of the λB site(Eisenbeis et al., 1995).”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Eisenbeis et al., 1995
In the citing paper
“This domain interacts with interferon regulatory factors (IRFs), including Pip/NF-EM5 and interferon consensus sequence binding protein (ICSBP) [44–46].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [46]
In the citing paper
“Another highly homologous IRF family member, IRF-8/ICSBP, competes with Pip/IRF-4 for binding to PU.1 on the enhancer element and thus represses the transactivation activity of the complex [46].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [46]
In the citing paper
“IRF-4 is similar to ICSBP in structure, interacts with some common partners (PU.1 and E47), and regulates an overlapping set of target promoters. (31,32,63,64)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [31]
In the citing paper
“IRF-4 is similar to ICSBP in structure, interacts with some common partners (PU.1 and E47), and regulates an overlapping set of target promoters. (31,32,63,64)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [31]
In the citing paper
“IRF-4 is similar to ICSBP in structure, interacts with some common partners (PU.1 and E47), and regulates an overlapping set of target promoters. (31,32,63,64)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [31]
In the citing paper
“PIP is expressed exclusively in the lymphoid lineages (27”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,090
Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S. W., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,541
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Self-citationBanerji, J., Olson, L., & Schaffner, W. (1983) · Cell · doi:10.1016/0092-8674(83)90015-6 · Cited by 1,381
Gillies, S. D., Morrison, S. L., Oi, V. T., & Tonegawa, S. (1983) · Cell · doi:10.1016/0092-8674(83)90014-4 · Cited by 1,361
Courey, A. J., & Tjian, R. (1988) · Cell · doi:10.1016/0092-8674(88)90144-4 · Cited by 1,353
Stewart, W. E. (1979) · Springer eBooks · doi:10.1007/978-3-7091-3432-0 · Cited by 1,165
Singh, H., Sen, R., Baltimore, D., & Sharp, P. A. (1986) · Nature · doi:10.1038/319154a0 · Cited by 1,087
Self-citation
Flagged first, then by citations
1 of the 58 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 447
Furui, J., Uegaki, K., Yamazaki, T., Shirakawa, M., Swindells, M. B., Harada, H., Taniguchi, T., & Kyogoku, Y. (1998) · Structure · doi:10.1016/s0969-2126(98)00050-1 · Cited by 25
Gupta, S. K., Xia, D., Jiang, M., Lee, S.-J., & Pernis, A. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5997 · Cited by 23
Pedchenko, T. V., Park, G. Y., Joo, M., Blackwell, T. S., & Christman, J. W. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00046.2005 · Cited by 24
Ochiai, K., Shima, H., Tamahara, T., Sugie, N., Funayama, R., Nakayama, K., Kurosaki, T., & Igarashi, K. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00077-6 · Cited by 24
Dilworth, D., Gudavicius, G., Leung, A., & Nelson, C. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-045 · Cited by 25
Regulation pattern of fish irf4 (the gene encoding IFN regulatory factor 4) by STAT6, c-Rel and IRF4
Li, S., Guo, X., Lu, L.-F., Lu, X.-B., Wu, N., & Zhang, Y. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.02.018 · Cited by 24
Matsumoto, M., Hisatake, K., Nogi, Y., & Tsujimoto, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104299200 · Cited by 24
Active repression of IFN regulatory factor-1-mediated transactivation by IFN regulatory factor-4
Yoshida, K., Yamamoto, K., Kohno, T., Hironaka, N., Yasui, K., Kojima, C., Mukae, H., Kadota, J., Suzuki, S., Honma, K., et al. (2005) · International Immunology · doi:10.1093/intimm/dxh324 · Cited by 26
Regulation of gene expression at early stages of B-cell and T-cell differentation
Fitzsimmons, D., & Hagman, J. R. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80054-9 · Cited by 24
Azagra, A., Marina-Zárate, E., Ramiro, A. R., Javierre, B. M., & Parra, M. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.11.006 · Cited by 25
Inflammasome is a central player in B cell development and homing
Hsu, M. L., & Zouali, M. (2022) · Life Science Alliance · doi:10.26508/lsa.202201700 · Cited by 22
Transcriptional reprogramming by mutated IRF4 in lymphoma
Schleußner, N., Cauchy, P., Franke, V., Giefing, M., Fornés, O., Vankadari, N., Assi, S. A., Costanza, M., Weniger, M. A., Akalin, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41954-8 · Cited by 26
Phospholipase Cγ2 Contributes to Light-Chain Gene Activation and Receptor Editing
Bai, L., Chen, Y., He, Y., Dai, X., Lin, X., Wen, R., & Wang, D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02273-06 · Cited by 22
Critical Functions of IRF4 in B and T Lymphocytes
Hagman, J. R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701385 · Cited by 22
Kasibhatla, S., Tailor, P., Bonnefoy, N., Mustelin, T., Altman, A., & Fotedar, A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2021 · Cited by 22
Oncogene dependency and the potential of targeted RNAi-based anti-cancer therapy
Yan, R., Hallam, A., Stockley, P. G., & Boyes, J. (2014) · Biochemical Journal · doi:10.1042/bj20140173 · Cited by 21
Epigenetics and the IRFs: A complex interplay in the control of immunity and autoimmunity
Rogatsky, I., Chandrasekaran, U., Manni, M., Yi, W., & Pernis, A. B. (2013) · Autoimmunity · doi:10.3109/08916934.2013.853050 · Cited by 20
Bragança, J., & Civas, A. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80021-2 · Cited by 21
Patel, K., Padhya, T. A., Huang, J., Hernandez-Prera, J. C., Li, T., Chung, C. H., Wang, L., & Wang, X. (2023) · Molecular Carcinogenesis · doi:10.1002/mc.23501 · Cited by 20
Wittekindt, N. E. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.800 · Cited by 20
Cloning of an interferon regulatory factor 2 isoform with different regulatory ability
Merediz, S. A. K. X. F. N. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4219 · Cited by 20
Nagulapalli, S., Goheer, A., Pitt, L. K., McIntosh, L. P., & Atchison, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7337-7350.2002 · Cited by 20
The Molecular Choreography of IRF4 and IRF8 with Immune System PartnersPreprint
Singh, H., Glasmacher, E., Chang, A. B., & Lugt, B. V. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020305 · Cited by 20
Self-citationBreig, O., Théoleyre, O., Douablin, A., & Baklouti, F. (2010) · Oncogene · doi:10.1038/onc.2010.29 · Cited by 19
Context-dependent Pax-5 repression of a PU.1/NF-κB regulated reporter gene in B lineage cells
Linderson, Y., French, N. S., Neurath, M. F., & Pettersson, S. (2001) · Gene · doi:10.1016/s0378-1119(00)00546-1 · Cited by 19
Exploring Functional Redundancy in the Immunoglobulin μ Heavy-Chain Gene Enhancer
Dang, W., Nikolajczyk, B. S., & Sen, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6870 · Cited by 19
Liu, X., Prabhu, A., & Ness, B. V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3285 · Cited by 19
Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8
Anderson, D. A., Ou, F., Kim, S. K., Murphy, T. L., & MURPHY, K. M. M. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211483 · Cited by 18
Perini, T., Materozzi, M., & Milan, E. (2021) · FEBS Journal · doi:10.1111/febs.16068 · Cited by 18
Pub, a novel PU.1 binding protein, regulates the transcriptional activity of PU.1
Hirose, S., Nishizumi, H., & Sakano, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.212 · Cited by 18
Carlsson, R., Persson, C., & Leanderson, T. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00032-4 · Cited by 18
PU.1 regulates the expression of the human neutrophil elastase gene
Srikanth, S., & Rado, T. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00039-6 · Cited by 18
Backbone dynamics of a short PU.1 ETS domain 1 1Edited by P. E. Wright
Jia, X., Lee, L. K., Light, J. P., Palmer, A. G. I., & Assa‐Munt, N. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3123 · Cited by 18
Co-crystallization of an ETS Domain (PU.1) in Complex with DNA
Pio, F., Ni, C., Mitchell, R. S., Knight, J., McKercher, S. R., Klemsz, M. J., Lombardo, A. M., Maki, R. A., & Ely, K. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24258 · Cited by 17
Crystallization and characterization of PU.1/IRF-4/DNA ternary complex
Escalante, C. R., Shen, L., Escalante, M. C., Brass, A. L., Edwards, T. A., Singh, H., & Aggarwal, A. K. (2002) · Journal of Structural Biology · doi:10.1016/s1047-8477(02)00514-2 · Cited by 17
Self-citationICSAT Overexpression Is Not Sufficient to Cause Adult T-Cell Leukemia or Multiple Myeloma
Saito, T., Yamagata, T., Takahashi, T., Honda, H., & Hirai, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0911 · Cited by 17
Role of the Transcription Factor BSAP (Pax-5) in B-Cell Development
Busslinger, M., & Nutt, S. L. (1998) · Humana Press eBooks · doi:10.1007/978-1-4757-2778-4_6 · Cited by 17
Guo, Z., Xu, P., Ge, S., Zhang, C., Zheng, X., Xu, J., Liu, Z., Li, B., & Ge, S. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3087 · Cited by 16
Li, X., Zhai, S., Zhang, J., Zhang, D., Wang, S., Wang, L., & Yu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698465 · Cited by 16
Satyaraj, E., & Storb, U. (1998) · PubMed · Cited by 16
Self-citationManzella, L., Gualdi, R., Perrotti, D., Nicolaides, N. C., Girlando, G., Giuffrida, M. A., Messina, A., & Calabretta, B. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4794 · Cited by 16
Gathany, A., Hartge, P. A., Davis, S., Cerhan, J. R., Severson, R. K., Cozen, W., Rothman, N., Chanock, S. J., & Wang, S. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9348-5 · Cited by 16
Mef2 Proteins, Required for Muscle Differentiation, Bind an Essential Site in the Ig λ Enhancer
Satyaraj, E., & Storb, U. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4795 · Cited by 16
Self-citationLuo, H., & Tian, M. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.016 · Cited by 15
Downregulation of IRF4 induces lytic reactivation of KSHV in primary effusion lymphoma cells
Forero, A., McCormick, K. D., Jenkins, F. J., & Sarkar, S. N. (2014) · Virology · doi:10.1016/j.virol.2014.04.020 · Cited by 14
Liu, H., Duan, Z., Zheng, H., Hu, D., Li, M., Tao, Y., Bode, A. M., Dong, Z., & Cao, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032624 · Cited by 15
A dichotomy of gene regulatory associations during the activated B-cell to plasmablast transition
Cocco, M., Care, M. A., Saadi, A., Maskari, M. A., Doody, G. M., & Tooze, R. M. (2020) · Life Science Alliance · doi:10.26508/lsa.202000654 · Cited by 15
FEIGENBLUM, D. Y., WALKER, R. E., & Schneider, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9257-9266.1998 · Cited by 15
Heydemann, A., Boehmler, J. H., & Simon, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29527 · Cited by 15
Confirming the Functional Importance of a Protein–DNA InteractionPreprint
Carey, M., Peterson, C. L., & Smale, S. T. (2012) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top070060 · Cited by 15
Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells
Miura, R., Kasakura, K., Nakano, N., Hara, M., Maeda, K., Okumura, K., Ogawa, H., Yashiro, T., & Nishiyama, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154094 · Cited by 14
Regulation of Human Igλ Light Chain Gene Expression by NF-κB
Combriato, G., & Klobeck, H.-G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1259 · Cited by 14
Circulating IRF8-expressing CD123+CD127+ lymphoid progenitors: key players in human hematopoiesis
Liang, K. L., Laurenti, E., & Taghon, T. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.07.004 · Cited by 13
PKCη directs induction of IRF-4 expression and Ig κ gene rearrangement in pre-BCR signaling pathway
Oda, A., Ono, T., Yamamoto, M., Goitsuka, R., & Kitamura, D. (2008) · International Immunology · doi:10.1093/intimm/dxn101 · Cited by 13
The mechanism of action of Spi-B in the transcriptional activation of the interferon-α4 gene
Miyazaki, R., Saiga, H., Takumi, K., Bakoshi, T., Senba, R., Shintani, A., Suzuki, M., Takao, K., Sasaki, I., Iizuka, A., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.101 · Cited by 13
Cloning and Promoter Analysis of the Chicken Interferon Regulatory Factor-3 Gene
May, D. L., Grant, C. E., & Deeley, R. G. (2000) · DNA and Cell Biology · doi:10.1089/104454900439782 · Cited by 14
Global Gene Expression Profiling in the Study of Multiple Myeloma
Shaughnessy, J. D. (2003) · International Journal of Hematology · doi:10.1007/bf02983777 · Cited by 13
PU.1 silencing leads to terminal differentiation of erythroleukemia cells
Atar, O., & Levi, B.-Z. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.109 · Cited by 13
Interferon regulatory factor-4 activates IL-2 and IL-4 promoters in cooperation with c-Rel
Shindo, H., Yasui, K., Yamamoto, K., Honma, K., Yui, K., Kohno, T., Ma, Y., Chua, K. J., Kubo, Y., Aihara, H., et al. (2011) · Cytokine · doi:10.1016/j.cyto.2011.08.014 · Cited by 12
Dimberg, A., Kårehed, K., Nilsson, K., & Oberg, F. G. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01827.x · Cited by 12
DNA binding and transcription activation by chicken interferon regulatory factor-3 (chIRF-3)
Grant, C. E. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.23.4790 · Cited by 12
Interferon Induces Up-regulation of Spi-1/PU.1 in Human Leukemia K562 Cells
Gutiérrez, P., Delgado, M. D., Richard, C., Moreau-Gachelin, F., & León, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7760 · Cited by 12
Torlakovic, E., Małecka, A., Myklebust, J. H., Tierens, A. M., Aasheim, H., Nesland, J. M., Smeland, E. B., Kvaløy, S., & Delabie, J. (2005) · The Journal of Pathology · doi:10.1002/path.1777 · Cited by 11
Glozak, M. A., & Blomberg, B. B. (1996) · Molecular Immunology · doi:10.1016/0161-5890(95)00146-8 · Cited by 10
Hodawadekar, S., Park, K., Farrar, M. A., & Atchison, M. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102239 · Cited by 10
Transcription of Immunoglobulin Genes
Calame, K. L., & Sen, R. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50007-1 · Cited by 11
B Lymphocyte Development and Transcription Regulation in Vivo
Opstelten, D. (1996) · Advances in immunology · doi:10.1016/s0065-2776(08)60857-3 · Cited by 10
Nakano, N., Nishiyama, C., Masuoka, N., Nishiyama, M., Yamane, H., Okumura, K., & Ogawa, H. (2005) · Immunogenetics · doi:10.1007/s00251-004-0754-2 · Cited by 11
Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia
Pingul, B. Y., Huang, H., Chen, Q., Alikarami, F., Zhang, Z., Qi, J., Bernt, K. M., Berger, S. L., Cao, Z., & Shi, J. (2022) · iScience · doi:10.1016/j.isci.2022.105139 · Cited by 10
IRF4 as an Oncogenic Biomarker for Hematological Malignancies
Ning, S. (2013) · Journal of Oncobiomarkers · doi:10.13188/2325-2340.1000003 · Cited by 10
Cai, M., & Chen, N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.817069 · Cited by 10
Transcriptional repression of type I IFN genes
Lopez, S., & Navarro, S. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80022-4 · Cited by 10
Dissecting regulatory syntax in human development with scalable multiomics and deep learningPreprint
Liu, B. B., Jessa, S., Kim, S. H., Ng, Y. T., Higashino, S. I., Marinov, G. K., Chen, D. C., Parks, B. E., Li, L., Nguyen, T. C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.30.651381 · Cited by 10
Wu, J., Ge, D., Zhong, T., Chen, Z., Zhou, Y., Hou, L., Lin, X., Hong, J., Liu, K., Qi, H. M., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01368-2 · Cited by 9
miR-142 keeps CD4+ DCs in balance
Belz, G. T. (2013) · Blood · doi:10.1182/blood-2012-12-472589 · Cited by 9
Exploring novel functions of BACH2 in the acquisition of antigen-specific antibodies
Ochiai, K., & Igarashi, K. (2022) · International Immunology · doi:10.1093/intimm/dxac065 · Cited by 9
Chronic Lymphocytic Leukaemia: A Review of the Immuno-architecture
Rosati, S., & Kluin, P. M. (2005) · Springer eBooks · doi:10.1007/3-540-29933-5_6 · Cited by 9
Liu, D., Chen, J., Zhang, H., Hu, M., Lou, H., Liu, Q., Zhang, S., & Hu, G. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.04.012 · Cited by 9
Hashmueli, S. (2003) · International Immunology · doi:10.1093/intimm/dxg077 · Cited by 9
Ma, S. L., Sørensen, A. B., Kunder, S., Sørensen, K. D., Quintanilla‐Martínez, L., Morris, D. W., Schmidt, J., & Pedersen, F. S. (2006) · Virology · doi:10.1016/j.virol.2006.05.006 · Cited by 8
Haque, S. F. Y., Bevington, S. L., & Boyes, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.087 · Cited by 8
Liu, S., & Wang, Z. (2022) · Disease Markers · doi:10.1155/2022/2561673 · Cited by 8
Identification of distal silencing elements in the murine interferon-A11 gene promoter
Roffet, P., Lopez, S., Navarro, S., Bandu, M., Coulombel, C., Vignal, M., Doly, J., & Vodjdani, G. (1996) · Biochemical Journal · doi:10.1042/bj3170697 · Cited by 8
Lai, C. F., Wang, T., Yeh, M.-I., & Chen, T.-Y. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.08.033 · Cited by 7
Inhibition of Interferon Regulatory Factor 4 Attenuates Acute Liver Allograft Rejection in Mice
Zhao, W., Zhang, Z., Zhao, Q., Liu, M., & Wang, Y. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12318 · Cited by 7
Transcriptional Control of B Cell Activation
Corcoran, L. M. (2005) · Springer eBooks · doi:10.1007/3-540-26363-2_6 · Cited by 7
Marienfeld, R. B., Nanda, I., Zöller, B., Schmid, M., Rebbert, M. L., & JUNGWIRTH, C. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.219 · Cited by 7
Matsudo, H., Otsuka, A., Ozawa, Y., & Ono, M. (2003) · Gene · doi:10.1016/j.gene.2003.08.021 · Cited by 7
Wang, S., Yan, Q., Chen, P., Zhao, P., & Gu, A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-410 · Cited by 6
Ishii, H., Sen, R., & Pazin, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308973200 · Cited by 6
The Making of a cDC1 : Precision Programming of Progenitor Potential
Murphy, T. L., & MURPHY, K. M. M. (2025) · Immunological Reviews · doi:10.1111/imr.70081 · Cited by 8
Mi2β Shows Chromatin Enzyme Specificity by Erasing a DNase I-hypersensitive Site Established by ACF
Ishii, H., Du, H., Zhang, Z., Henderson, A., Sen, R., & Pazin, M. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807617200 · Cited by 5
Rizq, O., Mimura, N., Oshima, M., Momose, S., Takayama, N., Itokawa, N., Koide, S., Shibamiya, A., Miyamoto‐Nagai, Y., Rizk, M., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01928-7 · Cited by 7
Nishiya, N., Yamamoto, K., Imaizumi, Y., Kohno, T., & Matsuyama, T. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.05.001 · Cited by 5
Suhara, W., Yoneyama, M., Yonekawa, H., & Fujita, T. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021227 · Cited by 5
Insights into the transcriptional regulation of CD22 in B cell chronic lymphocytic leukemia
Enkhbayar, B., Lu, S., Tsai, H.-Y., Liang, S., Wu, S., Lin, K., & Angata, T. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108386 · Cited by 4
Signaling Molecules Affecting Immune Response
Hertzog, P. J., Fenner, J. E., & Mansell, A. S. (2005) · Elsevier eBooks · doi:10.1016/b978-012455900-4/50267-1 · Cited by 4
The transcription factor Spi-B is not required for somatic hypermutation
Kim, N. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00201-8 · Cited by 4
IRF-7: an Antiviral Factor and Beyond
Perrotti, E., Marsili, G., Sgarbanti, M., Remoli, A. L., Fragale, A., Acchioni, C., Orsatti, R., & Battistini, A. (2013) · Future Virology · doi:10.2217/fvl.13.88 · Cited by 4
Monogenic disorders of the IRF transcription factors
Stojcic, M. P., Yousefi, P., Biggs, C. M., & Turvey, S. E. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250939 · Cited by 4
Metadata
- Authors
- Eisenbeis, C. F., Singh, H., & Storb, U.
- Affiliations
- University of Chicago (US)
- ORCID
- Singh, H
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1995-06-01
- Volume
- 9
- Issue
- 11
- Pages
- 1377-1387
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2055192078
- Cited by
- 447
- References
- 58
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 7 · 2020: 12 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 8 · 2015: 6 · 2014: 11 · 2013: 17 · 2012: 15
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- American Cancer Society
- Arthritis Foundation
- National Institutes of Health
- U.S. Public Health Service (FM07183)
- National Institute of General Medical Sciences (T32GM007281, GM-07281)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- Pip, PU.1, composite components, transcriptional activation, ternary protein complex, B cells, T cells
- MeSH terms
- Interferon Regulatory Factor-4, Amino Acid Sequence, Base Sequence, Cell Line, Cloning, Molecular, DNA-Binding Proteins, Gene Expression Regulation, Humans, Lymphocytes, Molecular Sequence Data, Transcription Factors, Trans-Activators, Retroviridae Proteins, Oncogenic, Sequence Alignment, Interferon Regulatory Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review